The power of AI harnessed for intermediate to high-risk PE patients
Aidoc’s PE care coordination suite facilitates rapid triage of studies with suspected positive findings for PE as well as care coordination for intermediate to high-risk patients.
Includes the industry-first FDA-cleared solution for triage and notification of suspected pulmonary embolism, together with Imbio’s FDA-cleared automated RV/LV analysis
Proven to substantially reduce time to notification of suspected PE patients
FDA clearance PE (K190072)
Notifications across the entire clinical workflow
Aidoc’s care coordination solutions offer the most comprehensive integrations into the clinical workflow, with notifications made easily available on desktop, mobile and tablet.
Communication at your fingertips
AI-based activation to synchronize care coordination teams
Use the arrows to see it in action
We have been using the first version of this solution for the last six months and have seen the real impact this has had on addressing patients that require treatment beyond anticoagulation.
Having this subset of patients routed simultaneously to multiple stakeholders has shown a reduction in time to treatment and clear improvements in patient outcomes.
Dr. Irena Tocino
Professor and Vice Chair of Medical Informatics
Yale School of Medicine (YSM)
The PE Response Team (PERT) was established to provide rapid risk assessment along with execution of the patient management strategy.
One of the challenges of establishing a PERT program is making sure the right information is in the hands of the right clinician. In Aidoc, we have a partner with the ability to bring deep integration of AI into these native workflows. The outcome leads to enhanced patient eligibility for novel therapies and makes a significant change to patient management.
Dr. Akhil Khosla
Co-Director of the PERT program
Yale New-Haven Hospital
Clinical studies demonstrate the value of PE care coordination in improving patient outcomes
Reduction of hospital length of stay
A retrospective study was performed on patients with a pulmonary embolism (PE) diagnosis using data extracted from electronic health records (EHR). Modality choices, outcomes, and complications of the PE cases were compared across three periods:
The baseline population was compared to PE patients treated with PERT at 3-month intervals following PERT implementation, and as a combined group 18 months after implementation. Outcomes compared between the baseline population and PERT treated.
The development of an increasingly structured approach to pulmonary embolism management is associated with a reduction in hospital length of stay, a trend toward reduction in ICU length of stay and no changes in mortality.
PERT Activation and Improved Patient Outcomes
A prospective study was performed on 220 patients with CT-confirmed PE between January, 2019 and August, 2019. The total population was divided into 2 groups, ie, those with PERT activation and those without PERT activation. The impact of PERT activation on primary outcome (rate of readmission, major bleeds, and mortality), treatment approach, and length of stay was examined.
PERT activation overall was low (23%) and did not depend on patient clinical severity. Although roughly two-thirds (146; 66.4%) of all patients had intermediate-high risk PE, only 24.7% of those patients had PERT activation. PERT activation was associated with decreased mortality, hospital LOS, new O2 requirements, readmissions, and patients needing help with daily activities. PERT activation, while beneficial, was remarkably underutilized, with 75.3% of intermediate to high-risk PE patients not receiving PERT activation.
University Hospitals Cleveland Medical Center